WHO 1-2级脑膜瘤伽玛刀治疗后失败与水肿的相关因素
该回顾性研究纳入2009至2018年接受伽玛刀放射外科(GKRS)治疗的52例脑膜瘤患者,多数为女性(38/52,73%)且为WHO 1级(48/52,92%)。多变量分析显示男性(HR=8.42,P=0.045)和较大肿瘤体积(HR=1.27,P=0.011)与治疗失败相关,单变量分析显示较大肿瘤体积(HR=1.16,P=0.028)与放射性脑水肿相关。
要点
- 男性是GKRS治疗后脑膜瘤进展的独立预测因素(HR=8.42,P=0.045)。
- 较大肿瘤体积与治疗失败(HR=1.27,P=0.011)及放射性脑水肿(HR=1.16,P=0.028)相关。
- 治疗后进展中位时间5.9个月(范围2.7-18.3个月),进展率10%(5/52)。
核心结论
- 较大脑膜瘤体积和男性性别易导致GKRS治疗后肿瘤进展。
- 较大肿瘤体积也预测放射外科后脑水肿的发生。
研究设计与样本
- 回顾性队列研究,收集2009至2018年接受GKRS治疗的脑膜瘤患者数据。
- 共纳入52例患者,进行单变量和多变量建模分析治疗失败和脑水肿的预测因素。
主要发现
- 52例中5例(10%)出现肿瘤进展,中位进展时间5.9个月(范围2.7-18.3个月)。
- 多变量分析:男性与治疗失败相关(HR=8.42,P=0.045),较大肿瘤体积与治疗失败相关(HR=1.27,P=0.011)。
- 5例(10%)发生治疗相关脑水肿,单变量分析显示较大肿瘤体积与脑水肿相关(HR=1.16,P=0.028)。
关键数值与推荐
- 多数患者为女性(38/52,73%),WHO 1级脑膜瘤占92%(48/52)。
- 中位肿瘤体积3.49 cc(范围0.22-20.11 cc)。
临床怎么用
- 对于男性或较大体积脑膜瘤患者,GKRS治疗后应加强影像随访以早期发现进展。
- 较大肿瘤患者需警惕放射性脑水肿的发生。
局限性
- 回顾性研究设计,样本量较小(52例)。
- 单中心数据,结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Before the advent of radiosurgery, neurosurgical treatment of meningiomas typically involved gross total resection of the mass whenever surgery was deemed possible. Over the past 4 decades, though, Gamma Knife radiosurgery (GKRS) has proved to be an effective, minimally invasive means to control the growth of these tumors. However, the variables associated with treatment failure (regrowth or clinical progression) after GKRS and GKRS-related complications, such as cerebral edema, are less well understood. METHODS: We retrospectively collected data between 2009 and 2018 for patients who underwent GKRS for meningiomas. After data collection, we performed univariate and multivariable modeling of the factors that predict treatment failure and cerebral edema after GKRS. Hazard ratios (HR) and P values were determined for these variables. RESULTS: Fifty-two patients were included our analysis. The majority of patients were female (38/52,73%), and nearly all patients presented with a suspected or confirmed World Health Organization grade 1 meningioma (48/52, 92%). The median tumor volume was 3.49 cc (range, 0.22-20.11 cc). Evidence of meningioma progression after treatment developed in 5 patients (10%), with a median time to continued tumor growth of 5.9 months (range, 2.7-18.3 months). In multivariable analysis, patients in whom treatment failed were more likely to be male (HR = 8.42, P = 0.045) and to present with larger tumor volumes (HR = 1.27, P = 0.011). In addition, 5 patients (10%) experienced treatment-related cerebral edema. On univariate analysis, patients who experienced cerebral edema were more likely present with larger tumors (HR = 1.16, P = 0.028). CONCLUSIONS: Increasing meningioma size and male gender predispose to meningioma progression after treatment with GKRS. Increasing tumor size also predicts the development of postradiosurgery cerebral edema.
引用
- O'Connor KP, Algan O, Vesely SK, et al. Factors Associated with Treatment Failure and Radiosurgery-Related Edema in WHO Grade 1 and 2 Meningioma Patients Receiving Gamma Knife Radiosurgery. World Neurosurg. 2019. PMID: 31299310. doi:10.1016/j.wneu.2019.06.152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。